Drug-Induced Thrombotic Microangiopathy due to Cumulative Toxicity of Ixazomib

Drug-induced thrombotic microangiopathies (DTMAs) are increasingly being recognized as an important category of thrombotic microangiopathies (TMAs). Cancer therapeutic agents including proteasome inhibitors (PIs) are among the most common medications reported to cause DTMA. PIs could cause DTMA eith...

Full description

Saved in:
Bibliographic Details
Published in:Case Rep Hematol
Main Authors: Atallah-Yunes, Suheil Albert, Soe, Myat Han
Format: Artigo
Language:Inglês
Published: Hindawi 2018
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6051099/
https://ncbi.nlm.nih.gov/pubmed/30057831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/7063145
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items